跳至主要内容
临床试验/CTRI/2024/05/067172
CTRI/2024/05/067172尚未招募Phase 3 4

Comparison of the effect of two prophylactic doses of tablet melatonin on incidence of delirium in patients admitted in intensive care unit

Vardhman Mahavir Medical College and Safdarjung Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年5月20日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
Incidence of delirium

研究概览

简要总结

This study is a prospective, interventional study to compare the effect of two doses of tablet melatonin on occurrence of ICU delirium , with the hypothesis that 6mg dose of melatonin causes a significantly greater reduction in the incidence of delirium as compared to the 3mg dose in patients admitted in Intensive Care Unit. Oral Melatonin 6mg and 3mg will be administered within 48 hours of ICU admission in each groups and GCS, RASS and CAM ICU Scores will be performed by an ICU Doctor initially ,Baseline- on the day of admission and later twice a day, once at the start of the day at 09:00 AM and after giving melatonin at 09:00 PM for five days.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Preserved oral/enteral intake within the first 48 hours of ICU admission.
  • Patients requiring an ICU stay of at least 5 days.
  • Richmond Agitation Sedation Scale (RASS) score within + 2 or.
  • 2 on admission.

排除标准

  • Hemodynamically unstable patients or on vasopressor support
  • Patients on psychotropic medications or having known psychiatric illness
  • Patients with debilitating neurological diseases and low GCS less than 10 on admission
  • Pregnant patients
  • Patient with known or suspected allergy to melatonin.

结局指标

主要结局

Incidence of delirium

时间窗: Twice a day once at 9 am and after giving the melatonin tablet at 9pm for a period of 5 days

次要结局

  • 1. To compare length of Intensive Care Unit stay in 2 study groups.(2. To compare the incidence of headache, dizziness and day-time sleepiness between the)

研究者

发起方
Vardhman Mahavir Medical College and Safdarjung Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Ajith Kumar P

Vardhman Mahavir Medical College and Safdarjung Hospital

研究点 (1)

Loading locations...

相似试验